Showing 4261-4280 of 7110 for: Cochrane Systematic Reviews Back
- Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)
Cochrane Systematic Reviews, 7-Mar-2012
During epidemics, influenza attack rates in children may exceed 40%. Options for prevention and treatment currently include the neuraminidase inhibitors zanamivir and oseltamivir. Laninamivir octanoate, the prodrug of laninamivir, is currently being devel
- Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Systematic Reviews, 15-Feb-2016
Cystic fibrosis is the most common, life-threatening, recessively inherited disease of Caucasian populations. It is a multisystem disorder caused by a mutation in the gene encoding the cystic fibrosis transmembrane conductance regulator protein which is i
- Neuraxial anaesthesia for lower-limb revascularization
Cochrane Systematic Reviews, 10-Jun-2014
Lower-limb revascularization is a surgical procedure that is performed to restore an adequate blood supply to the limbs. Lower-limb revascularization surgery is used to reduce pain and sometimes to improve lower-limb function. Neuraxial anaesthesia is an
- Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews
Cochrane Systematic Reviews, 25-Jan-2014
Various beneficial effects derived from neuraxial blocks have been reported. However, it is unclear whether these effects have an influence on perioperative mortality and major pulmonary/cardiovascular complications.
- Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia
Cochrane Systematic Reviews, 25-Apr-2008
Since the 1950s neuroleptic medication has been extensively used to treat people with chronic mental illnesses such as schizophrenia. These drugs, however, have been also associated with a wide range of adverse effects, including movement disorders such a
- Neuromodulators for pain management in rheumatoid arthritis
Cochrane Systematic Reviews, 14-Feb-2012
Pain management is a high priority for patients with rheumatoid arthritis (RA). Despite deficiencies in research data, neuromodulators have gained widespread clinical acceptance as adjuvants in the management of patients with chronic musculoskeletal pain.
- Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
Cochrane Systematic Reviews, 12-Dec-2012
Patients with progressive diseases often experience muscle weakness, which impacts adversely on levels of independence and quality of life. In those who are unable or unwilling to undertake traditional forms of exercise, neuromuscular electrical stimulati
- Neuromuscular paralysis for newborn infants receiving mechanical ventilation
Cochrane Systematic Reviews, 11-Aug-2009
Ventilated newborn infants breathing in asynchrony with the ventilator are potentially exposed to more severe barotrauma and are at risk for complications such as pneumothorax or intraventricular haemorrhage. Neuromuscular paralysis, which eliminates the
- Neuroprotection for treatment of glaucoma in adults
Cochrane Systematic Reviews, 31-Jan-2013
Glaucoma is a heterogeneous group of conditions involving progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss. It is a leading cause of blindness worldwide. Open angle glaucoma (OAG), the commone
- Neuropsychological and psychological interventions for people with newly diagnosed epilepsy
Cochrane Systematic Reviews, 21-Jul-2015
Many people with epilepsy report experiencing psychological difficulties such as anxiety, depression and neuropsychological deficits including memory problems. Research has shown that these difficulties are often present not only for people with chronic e
- Neuropsychological rehabilitation for multiple sclerosis
Cochrane Systematic Reviews, 11-Feb-2014
This is an update of the Cochrane review 'Neuropsychological rehabilitation for multiple sclerosis' (first published in The Cochrane Library 2011, Issue 11).
- Neuroreflexotherapy for non-specific low-back pain
Cochrane Systematic Reviews, 18-Jan-2011
Among the wide range of therapeutic alternatives proposed for the management of low-back pain (LBP), a less widely used technique from Spain, called neuroreflexotherapy (NRT) has claimed to show very favourable results, mainly in patients with chronic low
- Neurosurgical interventions for the treatment of classical trigeminal neuralgia
Cochrane Systematic Reviews, 4-Nov-2011
Surgical interventions are used for trigeminal neuralgia when drug treatment fails. Surgical treatments divide into two main categories, ablative (destructive) or non-ablative. These treatments can be done at three different sites: peripherally, at the Ga
- New generation antidepressants for depression in children and adolescents: a network meta‐analysis
Cochrane Systematic Reviews, 24-May-2021
Major depressive disorders have a significant impact on children and adolescents, including on educational and vocational outcomes, interpersonal relationships, and physical and mental health and well-being. There is an association between major depressiv
- New generation antipsychotics for first episode schizophrenia
Cochrane Systematic Reviews, 17-Oct-2012
The new generation antipsychotics are associated with a lower risk of adverse effects compared with drugs such as haloperidol. Many treatment guidelines recommend the use of new generation ('atypical') antipsychotic drugs for people with a first episode o
- Newborn screening for cystic fibrosis
Cochrane Systematic Reviews, 11-Aug-2009
Does newborn screening for cystic fibrosis (CF) improve clinical outcomes, quality of life and survival?
- Newborn screening for homocystinuria
Cochrane Systematic Reviews, 3-Sep-2015
Homocystinuria is a rare inherited disorder due to a deficiency in cystathionine beta synthase. Individuals with this condition appear normal at birth but develop serious complications in childhood. Diagnosis and treatment started sufficiently early in li
- Newer atypical antipsychotic medication versus clozapine for schizophrenia
Cochrane Systematic Reviews, 18-Jan-2012
Clozapine is an atypical antipsychotic drug, which is claimed to have superior efficacy and to cause fewer movement disorders. However, clozapine carries a significant risk of serious blood disorders. Newer atypical antipsychotics are safer alternatives t
- Newer generation antidepressants for depressive disorders in children and adolescents
Cochrane Systematic Reviews, 17-Oct-2012
Depressive disorders are common in young people and are associated with significant negative impacts. Newer generation antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are often used, however evidence of their effectiveness i
- Nicergoline for dementia and other age associated forms of cognitive impairment
Cochrane Systematic Reviews, 4-Nov-2008
Nicergoline is an ergot derivative currently in use in over fifty countries for more than three decades, for the treatment of cognitive, affective, and behavioral disorders of older people. It was initially considered as a vasoactive drug and mainly presc
